Biofrontera Inc. Increase (Decrease) in Prepaid Expenses, Other
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Prepaid Expenses, Other of $830.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-10-03
- Biofrontera Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2023-03-31 was $830.00K.
- Biofrontera Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-12-31 was -$33.00K, a 100.82% decline year-over-year.
- Biofrontera Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-09-30 was -$423.00K.
- Biofrontera Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2022-06-30 was -$84.00K, a 370.97% decline year-over-year.
- Biofrontera Inc. increase (decrease) in prepaid expenses, other for fiscal 2020 was -$364.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2023-03-31 | $830.00K 10-Q · filed 2023-05-12 | $797.00K derived: sum of 2 quarters · filed 2023-10-03 | $374.00K derived: sum of 3 quarters · filed 2023-10-03 | $290.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-12-31 | -$33.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | -$456.00K derived: sum of 2 quarters · filed 2023-10-03 | -$540.00K derived: sum of 3 quarters · filed 2023-10-03 | -$4.15M 8-K · filed 2023-10-03 |
| 2022-09-30 | -$423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$507.00K derived: sum of 2 quarters · filed 2022-11-14 | -$4.12M 10-Q · filed 2022-11-14 | -$78.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$3.70M 10-Q · filed 2022-08-12 | $345.00K derived: sum of 3 quarters · filed 2023-10-03 | -$3.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-03-31 | -$3.61M 10-Q · filed 2023-05-12 | $429.00K derived: sum of 2 quarters · filed 2023-10-03 | $81.00K derived: sum of 3 quarters · filed 2023-10-03 | $112.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2021-12-31 | $4.04M derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $3.69M derived: sum of 2 quarters · filed 2023-10-03 | $3.73M derived: sum of 3 quarters · filed 2023-10-03 | $3.81M 8-K · filed 2023-10-03 |
| 2021-09-30 | -$348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$317.00K derived: sum of 2 quarters · filed 2022-11-14 | -$234.00K 10-Q · filed 2022-11-14 | -$79.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $114.00K 10-Q · filed 2022-08-12 | $269.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $83.00K 10-Q · filed 2022-05-13 | $238.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | -$364.00K 10-K · filed 2022-04-11 | ||
| 2020-09-30 | -$519.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |